[37] The MMACHC gene product is characterised as a cyanocobalamin reductase (cyanide-eliminating) and an alkylcobalamin reductase
It is not approved or intended for human or animal use, consumption, therapeutic use, clinical application, or diagnostic purposes
This phase lasts two days
This established the mechanistic rationale for NNMT inhibition
Administered by a trained healthcare provider, each injection is quick, personalized, and done with your individual needs in mind
However, mild side effects may include: Pain or swelling at the injection site Mild diarrhea Temporary itching or rash Always consult with a healthcare provider before beginning any new supplement regimen